Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28225505 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL27707116 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL15740526 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL14260907 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL18387973 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL24998924 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL29107067 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL4274121 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| SCHEMBL15740500 | 1.00 | HRH3 (0.38) | HRH3OPRM1L3MBTL1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL31094680 | 0.98 | L3MBTL1 (0.40) | HRH3OPRM1L3MBTL1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8092595-B1 | Self-assembly of water-soluble nanocrystals | SANDIA CORPORATION (US) | 2012-01-10 | — | — | US | claimed |
| US-RE41612-E1 | Method for making surfactant-templated thin films | SANDIA CORPORATION (US) | 2010-08-31 | — | — | US | claimed |
| CN-1824691-A | Method of preparing mesoporous thin film having low dielectric constant | SAMSUNG CORNING CO LTD (KR) | 2006-08-30 | — | — | CN | claimed |
| US-20060159938-A1 | Composition for forming low dielectric thin film comprising polymer nanoparticles and method of preparing low dielectric thin film using the same | SAMSUNG CORNING CO., LTD. (KR) | 2006-07-20 | — | — | US | claimed |
| US-20060145306-A1 | Composition for forming low dielectric thin film comprising porous nanoparticles and method of preparing low dielectric thin film using the same | SAMSUNG CORNING CO., LTD. (KR) | 2006-07-06 | — | — | US | claimed |
| US-20060110940-A1 | Method of preparing mesoporous thin film having low dielectric constant | SAMSUNG CORNING CO., LTD. (KR) | 2006-05-25 | — | — | US | claimed |
| US-20050163924-A1 | Porous surfactant mediated metal oxide films | 3M INNOVATIVE PROPERTIES COMPANY | 2005-07-28 | — | — | US | claimed |
| EP-1546054-A1 | POROUS SURFACTANT MEDIATED METAL OXIDE FILMS | 3M Innovative Properties Company (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2004026783-A1 | POROUS SURFACTANT MEDIATED METAL OXIDE FILMS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-04-01 | — | — | WO | claimed |
| US-6387453-B1 | Method for making surfactant-templated thin films | SANDIA CORPORATION | 2002-05-14 | — | — | US | claimed |
| US-6270846-B1 | MIXING A PRECURSOR SOL, A SOLVENT, WATER, A SURFACTANT, AND A HYDROPHOBIC POLYMER, WHEREIN SAID HYDROPHOBIC POLYMER IS SOLUBLE IN SAID SOL, AND COATING A SUBSTRATE WITH SAID HOMOGENEOUS MIXTURE TO FORM A THIN FILM, HEATING | SANDIA CORPORATION | 2001-08-07 | — | — | US | claimed |
| US-6264741-B1 | Self-assembly of nanocomposite materials | SANDIA CORPORATION | 2001-07-24 | — | — | US | claimed |
| US-20260146197-A1 | USE OF PEROXY GLUCONIC ACID IN VARIOUS TREATMENT FLUIDS | SECURE SPECIALTY CHEMICALS CORP. (CA) | 2026-05-28 | — | — | US | disclosed |
| US-12410357-B2 | Use of percitric acid in oil- and gas-field operations | SECURE SPECIALTY CHEMICALS CORP. (CA) | 2025-09-09 | — | — | US | disclosed |
| US-20240254381-A1 | USE OF PERCITRIC ACID IN OIL- AND GAS-FIELD OPERATIONS | SECURE SPECIALTY CHEMICALS CORP. (CA) | 2024-08-01 | — | — | US | disclosed |
| US-11840454-B2 | Hollow porous silicon-containing structures and method of formation | CLEMSON UNIVERSITY (US) | 2023-12-12 | — | — | US | disclosed |
| EP-1028817-A1 | ORDERED MESOPOROUS THIN FILMS | Sandia Corporation (US) | 2000-08-23 | — | — | EP | disclosed |
| US-6096469-A | INK RECEPTOR MEDIUM COMPRISING A SUBSTRATE AND INK RECEPTOR COMPRISING A MIXTURE OF SURFACTANT TEMPLATED MESOPOROUS PARTICLES SUCH AS SILICA PARTICLES, AND ORGANIC BINDER; INK FIXING PROPERTIES, INK ABSORPTION CAPACITY | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-08-01 | — | — | US | disclosed |
| WO-1999015280-A1 | ORDERED MESOPOROUS THIN FILMS | SANDIA CORPORATION (US) | 1999-04-01 | — | — | WO | disclosed |
| US-5858457-A | Process to form mesostructured films | SANDIA CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146197-A1 | USE OF PEROXY GLUCONIC ACID IN VARIOUS TREATMENT FLUIDS | G6PD, MGAM, PGD | HRH3 4063/4885OPRM1 3253/4885L3MBTL1 4734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.